Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Vaccinations01:51

Vaccinations

44.4K
Overview
44.4K
Cancer Vaccines01:30

Cancer Vaccines

358
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
358
Cross-reactivity00:42

Cross-reactivity

31.0K
Overview
31.0K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Maternal RSV Vaccination, Infant Nirsevimab, or Both: Interim Analysis of a Randomized Trial.

Pediatrics·2026
Same author

A Phase 3 study to assess the safety and immunogenicity of a quadrivalent meningococcal conjugate vaccine (MenACYW-TT) co-administered with routine pediatric vaccines in healthy infants in the USA and Puerto Rico.

Human vaccines & immunotherapeutics·2025
Same author

Baptism in a Pandemic: Infectious Diseases Clinical Research Consortium Network Design for Readiness and Response.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2025
Same author

Evaluation of Cellular Immune Responses After mRNA-1273 Vaccination in Children 6 Months to 11 Years of Age.

The Journal of infectious diseases·2025
Same author

Evaluation of Vancomycin Dose Needed to Achieve 24-Hour Area Under the Concentration-Time Curve to Minimum Inhibitory Concentration Ratio Greater Than or Equal to 400 Using Pharmacometric Approaches in Pediatric Intensive Care Patients.

Critical care explorations·2024
Same author

February 2024 ACIP Meeting Update: Meningococcal, RSV, COVID-19, and Other Vaccines.

Pediatrics·2024

相关实验视频

Updated: Jun 26, 2025

Generation of Recombinant Arenavirus for Vaccine Development in FDA-Approved Vero Cells
10:03

Generation of Recombinant Arenavirus for Vaccine Development in FDA-Approved Vero Cells

Published on: August 1, 2013

17.0K

疫苗开发 疫苗开发

Elizabeth A D Hammershaimb1, James D Campbell1

  • 1Center for Vaccine Development and Global Health, University of Maryland School of Medicine, 685 West Baltimore Street, Room 480, Baltimore, MD 21201, USA; Department of Pediatrics, University of Maryland School of Medicine, Baltimore, MD, USA.

Pediatric clinics of North America
|May 16, 2024
PubMed
概括

这篇文章回顾了流行病期间儿童疫苗开发的伦理考虑. 它检查了历史的疫苗示例和流行病准备疫苗的当前状态.

科学领域:

  • 疫苗学 疫苗学 疫苗学
  • 公共卫生道德 公共卫生道德
  • 流行病学 流行病学

背景情况:

  • 疫情防控需要强有力的儿科疫苗开发战略.
  • 历史上的流行病如天花,流感和COVID-19凸显了针对儿童的疫苗解决方案的需要.
  • 在开发和部署儿科疫苗时,道德考虑至关重要.
关键词:
炭病是一种人心病.在 COVID-19 疫情中,埃博拉病毒埃博拉病毒埃博拉病毒新出现的感染 新出现的感染流感是一次流感.蒙波克斯 (Mox Mpox) 是一个儿童疫苗的使用情况小天花是一种天花.

更多相关视频

Expression and Purification of Virus-like Particles for Vaccination
06:17

Expression and Purification of Virus-like Particles for Vaccination

Published on: June 2, 2016

21.9K
Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation
00:10

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation

Published on: August 21, 2019

7.5K

相关实验视频

Last Updated: Jun 26, 2025

Generation of Recombinant Arenavirus for Vaccine Development in FDA-Approved Vero Cells
10:03

Generation of Recombinant Arenavirus for Vaccine Development in FDA-Approved Vero Cells

Published on: August 1, 2013

17.0K
Expression and Purification of Virus-like Particles for Vaccination
06:17

Expression and Purification of Virus-like Particles for Vaccination

Published on: June 2, 2016

21.9K
Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation
00:10

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation

Published on: August 21, 2019

7.5K